Abstract
Objective
This study aims to develop standardized recommendations for the implementation of Automated Dispensing Systems (ADS) in oncology wards, focusing on enhancing patient safety, operational efficiency, and the integration of these systems into hospital workflows.
Method
A structured methodology was employed, combining documentary analysis of ADS practices at CHUIS, synthesis of strategies for implementation, and development of evidence-based recommendations validated by a multidisciplinary panel.
Results
The primary outcome of this study was the development of standardized recommendations tailored for ADS implementation in oncology wards. Key findings included the importance of phased planning, targeted training (60 h), and integration with existing hospital IT systems. These recommendations emphasized initial audits, stakeholder engagement, and continuous monitoring to ensure sustainable and replicable practices. Enhanced medication management processes, including reductions in cytotoxic drug costs (9%), expiration-related losses (98.3%), and stockouts (41.1%), further demonstrated the transformative potential of ADS.
Discussion
The study underscores the critical role of tailored, evidence-based strategies in facilitating successful ADS adoption. These recommendations align with international safety standards and provide a scalable framework adaptable to diverse oncology settings. Limitations include the need for further exploration of resource adaptability and long-term impact on patient outcomes. The integration of emerging technologies, such as AI, presents opportunities for future optimization.
Conclusion
This research highlights the value of standardized recommendations for ADS implementation in oncology wards. By addressing operational challenges and integrating innovative solutions, this study offers a practical model for enhancing oncology pharmacy practices globally.
Keywords
Get full access to this article
View all access options for this article.